Global Neurodegenerative Disease Market Research Report 2024(Status and Outlook)

Global Neurodegenerative Disease Market Research Report 2024(Status and Outlook)



Report Overview:

Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

The Global Neurodegenerative Disease Market Size was estimated at USD 5843.27 million in 2023 and is projected to reach USD 7017.91 million by 2029, exhibiting a CAGR of 3.10% during the forecast period.

This report provides a deep insight into the global Neurodegenerative Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurodegenerative Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurodegenerative Disease market in any manner.

Global Neurodegenerative Disease Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Pfizer

Merck Serono

Biogen Idec

TEVA

UCB

Boehringer Ingelheim

Sanofi

GlaxoSmithKline

Livzon Pharmaceutical

Haisco Pharmaceutical

Jingxin Pharmaceutical

Dongcheng Biochemicals

Hisun Pharmaceutical

Luye Pharma

Ark Pharmaceutical

Kanghong Pharmaceutical

Huahai Pharmaceutical

BORA PHARMACEUTICALS

Market Segmentation (by Type)

NMDA

SSRIs

Dopamine Inhibitors

Market Segmentation (by Application)

Parkinson’s Disease

Huntington Disease

Amyotrophic Lateral Sclerosis

Alzheimer’s Disease

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Neurodegenerative Disease Market

Overview of the regional outlook of the Neurodegenerative Disease Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurodegenerative Disease Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neurodegenerative Disease
1.2 Key Market Segments
1.2.1 Neurodegenerative Disease Segment by Type
1.2.2 Neurodegenerative Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurodegenerative Disease Market Overview
2.1 Global Market Overview
2.1.1 Global Neurodegenerative Disease Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurodegenerative Disease Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurodegenerative Disease Market Competitive Landscape
3.1 Global Neurodegenerative Disease Sales by Manufacturers (2019-2024)
3.2 Global Neurodegenerative Disease Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurodegenerative Disease Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurodegenerative Disease Sales Sites, Area Served, Product Type
3.6 Neurodegenerative Disease Market Competitive Situation and Trends
3.6.1 Neurodegenerative Disease Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurodegenerative Disease Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neurodegenerative Disease Industry Chain Analysis
4.1 Neurodegenerative Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neurodegenerative Disease Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neurodegenerative Disease Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurodegenerative Disease Sales Market Share by Type (2019-2024)
6.3 Global Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
6.4 Global Neurodegenerative Disease Price by Type (2019-2024)
7 Neurodegenerative Disease Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurodegenerative Disease Market Sales by Application (2019-2024)
7.3 Global Neurodegenerative Disease Market Size (M USD) by Application (2019-2024)
7.4 Global Neurodegenerative Disease Sales Growth Rate by Application (2019-2024)
8 Neurodegenerative Disease Market Segmentation by Region
8.1 Global Neurodegenerative Disease Sales by Region
8.1.1 Global Neurodegenerative Disease Sales by Region
8.1.2 Global Neurodegenerative Disease Sales Market Share by Region
8.2 North America
8.2.1 North America Neurodegenerative Disease Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurodegenerative Disease Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurodegenerative Disease Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurodegenerative Disease Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurodegenerative Disease Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Neurodegenerative Disease Basic Information
9.1.2 Novartis Neurodegenerative Disease Product Overview
9.1.3 Novartis Neurodegenerative Disease Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Neurodegenerative Disease SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Pfizer
9.2.1 Pfizer Neurodegenerative Disease Basic Information
9.2.2 Pfizer Neurodegenerative Disease Product Overview
9.2.3 Pfizer Neurodegenerative Disease Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Neurodegenerative Disease SWOT Analysis
9.2.6 Pfizer Recent Developments
9.3 Merck Serono
9.3.1 Merck Serono Neurodegenerative Disease Basic Information
9.3.2 Merck Serono Neurodegenerative Disease Product Overview
9.3.3 Merck Serono Neurodegenerative Disease Product Market Performance
9.3.4 Merck Serono Neurodegenerative Disease SWOT Analysis
9.3.5 Merck Serono Business Overview
9.3.6 Merck Serono Recent Developments
9.4 Biogen Idec
9.4.1 Biogen Idec Neurodegenerative Disease Basic Information
9.4.2 Biogen Idec Neurodegenerative Disease Product Overview
9.4.3 Biogen Idec Neurodegenerative Disease Product Market Performance
9.4.4 Biogen Idec Business Overview
9.4.5 Biogen Idec Recent Developments
9.5 TEVA
9.5.1 TEVA Neurodegenerative Disease Basic Information
9.5.2 TEVA Neurodegenerative Disease Product Overview
9.5.3 TEVA Neurodegenerative Disease Product Market Performance
9.5.4 TEVA Business Overview
9.5.5 TEVA Recent Developments
9.6 UCB
9.6.1 UCB Neurodegenerative Disease Basic Information
9.6.2 UCB Neurodegenerative Disease Product Overview
9.6.3 UCB Neurodegenerative Disease Product Market Performance
9.6.4 UCB Business Overview
9.6.5 UCB Recent Developments
9.7 Boehringer Ingelheim
9.7.1 Boehringer Ingelheim Neurodegenerative Disease Basic Information
9.7.2 Boehringer Ingelheim Neurodegenerative Disease Product Overview
9.7.3 Boehringer Ingelheim Neurodegenerative Disease Product Market Performance
9.7.4 Boehringer Ingelheim Business Overview
9.7.5 Boehringer Ingelheim Recent Developments
9.8 Sanofi
9.8.1 Sanofi Neurodegenerative Disease Basic Information
9.8.2 Sanofi Neurodegenerative Disease Product Overview
9.8.3 Sanofi Neurodegenerative Disease Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
9.9 GlaxoSmithKline
9.9.1 GlaxoSmithKline Neurodegenerative Disease Basic Information
9.9.2 GlaxoSmithKline Neurodegenerative Disease Product Overview
9.9.3 GlaxoSmithKline Neurodegenerative Disease Product Market Performance
9.9.4 GlaxoSmithKline Business Overview
9.9.5 GlaxoSmithKline Recent Developments
9.10 Livzon Pharmaceutical
9.10.1 Livzon Pharmaceutical Neurodegenerative Disease Basic Information
9.10.2 Livzon Pharmaceutical Neurodegenerative Disease Product Overview
9.10.3 Livzon Pharmaceutical Neurodegenerative Disease Product Market Performance
9.10.4 Livzon Pharmaceutical Business Overview
9.10.5 Livzon Pharmaceutical Recent Developments
9.11 Haisco Pharmaceutical
9.11.1 Haisco Pharmaceutical Neurodegenerative Disease Basic Information
9.11.2 Haisco Pharmaceutical Neurodegenerative Disease Product Overview
9.11.3 Haisco Pharmaceutical Neurodegenerative Disease Product Market Performance
9.11.4 Haisco Pharmaceutical Business Overview
9.11.5 Haisco Pharmaceutical Recent Developments
9.12 Jingxin Pharmaceutical
9.12.1 Jingxin Pharmaceutical Neurodegenerative Disease Basic Information
9.12.2 Jingxin Pharmaceutical Neurodegenerative Disease Product Overview
9.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Product Market Performance
9.12.4 Jingxin Pharmaceutical Business Overview
9.12.5 Jingxin Pharmaceutical Recent Developments
9.13 Dongcheng Biochemicals
9.13.1 Dongcheng Biochemicals Neurodegenerative Disease Basic Information
9.13.2 Dongcheng Biochemicals Neurodegenerative Disease Product Overview
9.13.3 Dongcheng Biochemicals Neurodegenerative Disease Product Market Performance
9.13.4 Dongcheng Biochemicals Business Overview
9.13.5 Dongcheng Biochemicals Recent Developments
9.14 Hisun Pharmaceutical
9.14.1 Hisun Pharmaceutical Neurodegenerative Disease Basic Information
9.14.2 Hisun Pharmaceutical Neurodegenerative Disease Product Overview
9.14.3 Hisun Pharmaceutical Neurodegenerative Disease Product Market Performance
9.14.4 Hisun Pharmaceutical Business Overview
9.14.5 Hisun Pharmaceutical Recent Developments
9.15 Luye Pharma
9.15.1 Luye Pharma Neurodegenerative Disease Basic Information
9.15.2 Luye Pharma Neurodegenerative Disease Product Overview
9.15.3 Luye Pharma Neurodegenerative Disease Product Market Performance
9.15.4 Luye Pharma Business Overview
9.15.5 Luye Pharma Recent Developments
9.16 Ark Pharmaceutical
9.16.1 Ark Pharmaceutical Neurodegenerative Disease Basic Information
9.16.2 Ark Pharmaceutical Neurodegenerative Disease Product Overview
9.16.3 Ark Pharmaceutical Neurodegenerative Disease Product Market Performance
9.16.4 Ark Pharmaceutical Business Overview
9.16.5 Ark Pharmaceutical Recent Developments
9.17 Kanghong Pharmaceutical
9.17.1 Kanghong Pharmaceutical Neurodegenerative Disease Basic Information
9.17.2 Kanghong Pharmaceutical Neurodegenerative Disease Product Overview
9.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Product Market Performance
9.17.4 Kanghong Pharmaceutical Business Overview
9.17.5 Kanghong Pharmaceutical Recent Developments
9.18 Huahai Pharmaceutical
9.18.1 Huahai Pharmaceutical Neurodegenerative Disease Basic Information
9.18.2 Huahai Pharmaceutical Neurodegenerative Disease Product Overview
9.18.3 Huahai Pharmaceutical Neurodegenerative Disease Product Market Performance
9.18.4 Huahai Pharmaceutical Business Overview
9.18.5 Huahai Pharmaceutical Recent Developments
9.19 BORA PHARMACEUTICALS
9.19.1 BORA PHARMACEUTICALS Neurodegenerative Disease Basic Information
9.19.2 BORA PHARMACEUTICALS Neurodegenerative Disease Product Overview
9.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Product Market Performance
9.19.4 BORA PHARMACEUTICALS Business Overview
9.19.5 BORA PHARMACEUTICALS Recent Developments
10 Neurodegenerative Disease Market Forecast by Region
10.1 Global Neurodegenerative Disease Market Size Forecast
10.2 Global Neurodegenerative Disease Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurodegenerative Disease Market Size Forecast by Country
10.2.3 Asia Pacific Neurodegenerative Disease Market Size Forecast by Region
10.2.4 South America Neurodegenerative Disease Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurodegenerative Disease by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neurodegenerative Disease Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurodegenerative Disease by Type (2025-2030)
11.1.2 Global Neurodegenerative Disease Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurodegenerative Disease by Type (2025-2030)
11.2 Global Neurodegenerative Disease Market Forecast by Application (2025-2030)
11.2.1 Global Neurodegenerative Disease Sales (Kilotons) Forecast by Application
11.2.2 Global Neurodegenerative Disease Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings